Total Funding
25
43
Total FundingSeed raised
Growth Score 25 in past quarter
-29 pts
Heat Score 43 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
128439
Artin Bioscience develops therapeutics for respiratory diseases.
- Charles Magolske: Co-founder, CEO
- Norbert Voelkel: Co-founder, Chief Medical Officer
About the Company
Artin Bioscience develops therapeutics for respiratory diseases. Artin Bioscience's mission is to develop and provide therapies for respiratory diseases, with their lead indications being COVID 19, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Arterial Hypertension (PAH).